Bartizal Ken 4
4 · Trius Therapeutics Inc · Filed Mar 11, 2013
Insider Transaction Report
Form 4
Bartizal Ken
Chief Development Officer
Transactions
- Award
Stock Option (right to buy)
2013-03-07+90,000→ 90,000 totalExercise: $6.13Exp: 2023-03-06→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests in 48 successive equal monthly installments over the four year period beginning on March 7, 2013.